Cite
HARVARD Citation
Bryant, A. et al. (2022). Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer. American journal of clinical oncology. pp. 142-145. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bryant, A. et al. (2022). Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer. American journal of clinical oncology. pp. 142-145. [Online].